{"id":"NCT01947491","sponsor":"Primus Pharmaceuticals","briefTitle":"A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2015-01","completion":"2015-01","firstPosted":"2013-09-20","resultsPosted":"2016-10-06","lastUpdate":"2024-03-07"},"enrollment":394,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"DFD01 Spray","otherNames":["Topical corticosteroid spray"]},{"type":"DRUG","name":"Comp01 Lotion","otherNames":["Topical corticosteroid lotion"]},{"type":"DRUG","name":"Vehicle Lotion","otherNames":[]},{"type":"DRUG","name":"Vehicle Spray","otherNames":[]}],"arms":[{"label":"DFD01 Spray","type":"EXPERIMENTAL"},{"label":"Vehicle Spray","type":"PLACEBO_COMPARATOR"},{"label":"Comp01 Lotion","type":"ACTIVE_COMPARATOR"},{"label":"Vehicle Lotion","type":"PLACEBO_COMPARATOR"}],"summary":"The objectives of this study are to compare the safety of DFD01 Spray to Comp01 Lotion for topical treatment of moderate plaque psoriasis and to compare the efficacy of DFD01 Spray to Placebo Spray for topical treatment of moderate plaque psoriasis after 28 days of treatment.","primaryOutcome":{"measure":"Percentage of Participants With Success According to the Investigator Global Assessment (IGA)","timeFrame":"Day 15","effectByArm":[{"arm":"DFD01 Spray","deltaMin":19,"sd":null},{"arm":"Vehicle Spray","deltaMin":2.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":40,"countries":["United States"]},"refs":{"pmids":["29657667"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":173},"commonTop":["Application Site Pain","Application Site Pruritis"]}}